Kibali isnt am asset yet so shouldn’t be included unless you also add the acquisition costs.Still I think we can all agree it’s undervalued pending financing issues being resolved.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game